The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive biomarkers of everolimus efficacy in HER2+ advanced breast cancer: Combined exploratory analysis from BOLERO-1 and BOLERO-3.
 
Dennis J. Slamon
Research Funding - Novartis
 
Sara A. Hurvitz
Honoraria - Genentech/Roche
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Dignitana (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Puma Biotechnology (Inst); sanofi (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Genentech/Roche; Lilly; Novartis; Pfizer
 
David Chen
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Fabrice Andre
Honoraria - AstraZeneca; Novartis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Novartis
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Roche
 
Ling-Ming Tseng
Honoraria - Celgene; Novartis; Roche Pharma AG
Consulting or Advisory Role - Celgene; Novartis
Research Funding - MSD; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Roche Pharma AG
 
Guy Heinrich Maria Jerusalem
Honoraria - Celgene; Novartis; Roche
Consulting or Advisory Role - Celgene; Novartis
Research Funding - MSD; Novartis; Roche
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Roche
 
Sharon Wilks
Honoraria - Genentech
Speakers' Bureau - Genentech
 
Ruth O'Regan
Honoraria - Genomic Health; Novartis; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; BIND Biosciences; Celgene; Johnson & Johnson; Novartis; Pfizer
Research Funding - Genentech (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - BIND Biosciences; Celgene; Genomic Health; Novartis; Roche
 
Claudine Isaacs
Honoraria - Celgene; Genentech/Roche
Speakers' Bureau - Celgene; Genentech
Research Funding - Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst)
 
Masakazu Toi
Research Funding - Novartis
 
Howard A. Burris
No Relationships to Disclose
 
Wei He
Employment - Novartis
 
Markus Riester
Stock and Other Ownership Interests - Foundation Medicine; Johnson & Johnson
 
Douglas Robinson
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Patents, Royalties, Other Intellectual Property - Novartis
Travel, Accommodations, Expenses - Novartis
 
Tanya Taran
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Luca Gianni
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Genomic Health; GlaxoSmithKline; Merck Sharp & Dohme; Pfizer; Roche; Synthon; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - Roche